{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:12:23Z","timestamp":1791645143946,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010376","name":"American Association of Clinical Endocrinologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.eprac.2021.11.080","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T02:03:50Z","timestamp":1636682630000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Vishal K.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4199-4844","authenticated-orcid":false,"given":"Lissa","family":"Padnick-Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherwin","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajib K.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Francis-Sedlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eprac.2021.11.080_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/eje.0.1480491","article-title":"Multi-center study on the characteristics and treatment strategies of patients with Graves\u2019 orbitopathy: the first European Group on Graves\u2019 Orbitopathy experience","volume":"148","author":"Prummel","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2021.11.080_bib2","series-title":"Graves\u2019 Orbitopathy: A Multidisciplinary Approach - Questions and Answers","first-page":"1","article-title":"Clinical manifestations","author":"Dickinson","year":"2017"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.080_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"10","key":"10.1016\/j.eprac.2021.11.080_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.080_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","article-title":"Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease","volume":"133","author":"Stein","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.080_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2011.09.004","article-title":"Prevention of Graves\u2019 ophthalmopathy","volume":"26","author":"Bartalena","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.080_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eprac.2020.11.011","article-title":"Risk factors of thyroid eye disease","volume":"27","author":"Lee","year":"2021","journal-title":"Endocrine Pract"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.080_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cen.12222","article-title":"Smoking and thyroid","volume":"79","author":"Wiersinga","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.eprac.2021.11.080_bib9","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.080_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/IOP.0000000000001437","article-title":"Serum vitamin D deficiency is an independent risk factor for thyroid eye disease","volume":"36","author":"Heisel","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.eprac.2021.11.080_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9394(14)72666-2","article-title":"The incidence of Graves\u2019 ophthalmopathy in Olmsted County, Minnesota","volume":"120","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.080_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archopht.1993.01090020051022","article-title":"The initial clinical characteristics of Graves\u2019 orbitopathy vary with age and sex","volume":"111","author":"Kendler","year":"1993","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.eprac.2021.11.080_bib13","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A\u00a0novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2019 orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.080_bib14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.4103\/ijo.IJO_1443_19","article-title":"Severity of thyroid eye disease and type-2 diabetes mellitus: Is there a correlation?","volume":"68","author":"Ramamurthy","year":"2020","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.eprac.2021.11.080_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/IOP.0000000000001871","article-title":"Sight-threatening thyroid eye disease: role of diabetes mellitus and interaction with other risk factors","volume":"37","author":"Rath","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"10","key":"10.1016\/j.eprac.2021.11.080_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves\u2019 ophthalmopathy","volume":"12","author":"Bartalena","year":"1989","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2021.11.080_bib17","first-page":"P396","article-title":"A\u00a0link between thyroid eye disease (TED) and diabetes? [abstract]","volume":"65","author":"Farag","year":"2019","journal-title":"Endocrine Abstracts"},{"issue":"4","key":"10.1016\/j.eprac.2021.11.080_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bjo.83.4.463","article-title":"Diabetes mellitus: a risk factor in patients with Graves\u2019 orbitopathy","volume":"83","author":"Kalmann","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.eprac.2021.11.080_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.numecd.2015.01.003","article-title":"Type 2 diabetic patients with Graves\u2019 disease have more frequent and severe Graves\u2019 orbitopathy","volume":"25","author":"Le Moli","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"10.1016\/j.eprac.2021.11.080_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.15585\/mmwr.mm6712a2","article-title":"Prevalence of diagnosed diabetes in adults by diabetes type\u2014United States, 2016","volume":"67","author":"Bullard","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.eprac.2021.11.080_bib21","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1210\/jc.2016-1915","article-title":"Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass","volume":"101","author":"Nordstr\u00f6m","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2021.11.080_bib23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0161-6420(88)32978-7","article-title":"Dysthyroid optic neuropathy: the crowded orbital apex syndrome","volume":"95","author":"Neigel","year":"1988","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.eprac.2021.11.080_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076653","article-title":"The association between diabetes mellitus and nonarteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis","volume":"8","author":"Chen","year":"2013","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.080_bib25","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.exer.2009.01.009","article-title":"Investigating structural and biochemical correlates of ganglion cell dysfunction in streptozotocin-induced diabetic rats","volume":"88","author":"Bui","year":"2009","journal-title":"Exp Eye Research"},{"issue":"5","key":"10.1016\/j.eprac.2021.11.080_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archopht.1994.01090170088028","article-title":"Risk factors for the development of glaucomatous visual field loss in ocular hypertension","volume":"112","author":"Quigley","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.eprac.2021.11.080_bib27","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archopht.1996.01100140566007","article-title":"Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.080_bib28","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1167\/iovs.06-0076","article-title":"Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy","volume":"47","author":"Diederen","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5-6","key":"10.1016\/j.eprac.2021.11.080_bib29","first-page":"205","article-title":"Alterations in retrograde axonal transport in optic nerve of type I and type II diabetic rats","volume":"44","author":"Zhang","year":"1998","journal-title":"Kobe J Med Sci"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.080_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1444-0938.2010.00546.x","article-title":"Clinical and experimental links between diabetes and glaucoma","volume":"94","author":"Wong","year":"2011","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.eprac.2021.11.080_bib31","doi-asserted-by":"crossref","first-page":"k1497","DOI":"10.1136\/bmj.k1497","article-title":"Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study","volume":"362","author":"Xu","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.eprac.2021.11.080_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pcd.2011.06.001","article-title":"Graves\u2019 disease in subjects with type 1 diabetes mellitus: a prevalence study in western Sicily (Italy)","volume":"5","author":"Greco","year":"2011","journal-title":"Prim Care Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2021.11.080_bib33","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40264-015-0339-z","article-title":"Drug-induced hyperglycaemia and diabetes","volume":"38","author":"Fathallah","year":"2015","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.080_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-8587(21)00056-5","article-title":"Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials","volume":"9","author":"Kahaly","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.080_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/er.2018-00163","article-title":"Thyroid dysfunction and diabetes mellitus: two closely associated disorders","volume":"40","author":"Biondi","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.eprac.2021.11.080_bib36","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/jc.2005-1679","article-title":"Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening","volume":"91","author":"Barker","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2021.11.080_bib37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Fr\u00f6hlich","year":"2017","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.eprac.2021.11.080_bib38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0035-1559633","article-title":"Graves\u2019 disease mechanisms: the role of stimulating, blocking, and cleavage region TSH receptor antibodies","volume":"47","author":"Morshed","year":"2015","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.eprac.2021.11.080_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2018-01493","article-title":"Potential roles of CD34+ fibrocytes masquerading as orbital fibroblasts in thyroid-associated ophthalmopathy","volume":"104","author":"Smith","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2021.11.080_bib40","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00125-012-2463-y","article-title":"Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway","volume":"55","author":"S\u00f8rgjerd","year":"2012","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.080_bib41","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/jcem.87.3.8343","article-title":"Glutamic acid decarboxylase antibody positivity is associated with an impaired insulin response to glucose and arginine in nondiabetic paitents with autoimmune thyroiditis","volume":"87","author":"Lethagen","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.080_bib42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/er.2018-00066","article-title":"Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy","volume":"40","author":"Smith","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.eprac.2021.11.080_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.080_bib44","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.eprac.2021.11.080_bib45","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.4049\/jimmunol.181.8.5768","article-title":"B\u00a0cells from patients with Graves\u2019 disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis","volume":"181","author":"Douglas","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.eprac.2021.11.080_bib46","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.178.5.3281","article-title":"Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves\u2019 disease may carry functional consequences for disease pathogenesis","volume":"178","author":"Douglas","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.080_bib47","first-page":"872","article-title":"Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes","volume":"79","author":"Brismar","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2021.11.080_bib48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/RHU.0000000000000140","article-title":"A\u00a0pilot study on dual-energy computed tomography for detection of urate deposits in renal transplant patients with asymptomatic hyperuricemia","volume":"20","author":"Kimura-Hayama","year":"2014","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.eprac.2021.11.080_bib49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","article-title":"Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2021.11.080_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","article-title":"Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21013732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21013732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:37Z","timestamp":1761516757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X21013732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1530891X21013732"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2021.11.080","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2021.11.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}